Newsbenzinga
Scholar Rock Marks 'Defining Moment' with First Muscle-Targeted Treatment for Spinal Muscular Atrophy
· Published
Article summary
FDA approves Scholar Rock Isembyld to treat spinal muscular atrophy in adults and pediatric patients two years and older.
An excerpt from the original article.
Comments —
Loading comments…